GlobeNewsWire
27 Jun 2026, 14:10 UTC · 11w ago
Verdict
Headline leans bearish. We score ZTS −1.00 across four claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
4 claims · scored −1 bearish … +1 bullish
A securities fraud class action lawsuit has been filed against ADMA Biologics alleging the company used 'channel stuffing' to artificially inflate revenue growth.
More negative than 98% of claims this week
Culper Research reported that ADMA Biologics allegedly induced distributors to stock excess ASCENIV via rebates and extended payment terms to meet order expectations.
So whatThis provides a specific mechanism for the alleged fraud, suggesting that reported 20% growth may actually be -3% real growth.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 96% of claims this week
The lawsuit alleges ADMA Biologics engaged in an undisclosed related party transaction and lacked adequate internal controls.
More negative than 86% of claims this week
ADMA Biologics' stock price fell 29.1% over two trading days following the publication of the Culper Research report.
More negative than 73% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is the subject of a securities fraud class action lawsuit investigation.
More negative than 96% of ticker scores this week
The company is facing a securities fraud class action lawsuit following allegations of channel stuffing and undisclosed related party transactions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
3h ago
−3.1%
Price agrees with the score
$73.76 vs $76.09 close before publication (Jun 26) · not market-adjusted
ZTS chart →
